FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3186311000001101: Selegiline 1.25mg oral lyophilisates sugar free 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22200501000001119 Selegiline 1.25mg oral lyophilisates sugar free 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22200601000001115 Selegiline 1.25mg oral lyophilisates sugar free 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet Is pack of Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet Has active ingredient Selegiline hydrochloride false Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet Has VMP Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet Has specific active ingredient Selegiline hydrochloride true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet Has dispensed dose form Conventional release oral lyophilisate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Is a True Selegiline 1.25mg oral lyophilisates sugar free 30 tablet Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (CST Pharma Ltd) 30 tablet Is a True Selegiline 1.25mg oral lyophilisates sugar free 30 tablet Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Is a True Selegiline 1.25mg oral lyophilisates sugar free 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start